| Sowa, M., B. J. Arthurs, B. J. Estes, and W. F. Morgan. Effects of ionizing radiation on cellular structures, induced instability and carcinogenesis. EXS 96:293–301.(2006). PubMed | | Elmore, E., X-Y. Lao, R. Kapadia, and J. L. Redpath. The effect of dose rate on radiation-induced neoplastic transformation in vitro by low doses of low-LET radiation. Radiat. Res 166:832–838.(2006). BioOne, PubMed | | Suit, H., S. Goldberg, A. Niemierko, M. Ancukiewicz, E. Hall, M. Goitein, W. Wong, and H. Paganetti. Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat. Res 167:12–42.(2007). BioOne, PubMed | | Turner, N. D., L. A. Braby, J. Ford, and J. R. Lupton. Opportunities for nutritional amelioration of radiation-induced cellular damage. Nutrition 18:904–912.(2002). CrossRef, PubMed, CSA | | Arora, R., D. Gupta, R. Chawla, R. Sagar, A. Sharma, R. Kumar, J. Prasad, S. Singh, N. Samanta, and R. K. Sharma. Radioprotection by plant products: Present status and future prospects. Phytother. Res 19:1–22.(2005). CrossRef, PubMed | | Rimando, A. M., W. Kalt, J. B. Magee, J. Dewey, and J. R. Ballington. Resveratrol, pterostilbene, and piceatannol in Vaccinium berries. J. Agric. Food Chem 52:4713–4719.(2004). CrossRef, PubMed | | Burns, J., T. Yokota, H. Ashihara, M. E J. Lean, and A. Crozier. Plant and herbal sources of resveratrol. J. Agric. Food Chem 50:3337–3340.(2002). CrossRef, PubMed, CSA | | Baur, J. A. and D. A. Sinclair. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Disc 5:493–506.(2006). CrossRef, PubMed | | Li, Y., Z. Cao, and H. Zhu. Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol. Res 53:6–15.(2006). CrossRef, PubMed | | Losa, G. A. Resveratrol modulates apoptosis and oxidation in human blood mononuclear cells. Eur. J. Clin. Invest 33:818–823.(2003). CrossRef, PubMed, CSA | | Clement, M-V., J. L. Hirpara, S-H. Chawdhury, and S. Pervaiz. Chemopreventive agent resveratrol, natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92:996–1002.(1998). PubMed | | Huang, C., W. Ma, A. Goranson, and Z. Dong. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20:237–242.(1999). CrossRef, PubMed, CSA | | She, Q-B., A. M. Bode, W-Y. Ma, N-Y. Chen, and Z. Dong. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular signal-regulated protein kinases and p38 kinase. Cancer Res 61:1604–1610.(2001). PubMed, CSA | | Surh, Y-J., Y-J. Hurh, J-Y. Kang, E. Lee, G. Kong, and S. J. Lee. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett 140:1–10.(1999). CrossRef, PubMed, CSA | | Tessitore, L., A. Davit, I. Sarotto, and G. Caderni. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21 (CIP) expression. Carcinogenesis 21:1619–1622.(2000). CrossRef, PubMed, CSA | | Delmas, D., A. Lancon, D. Colin, B. Jannin, and N. Latruffe. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr. Drug Targets 7:423–442.(2006). CrossRef, PubMed | | Kundu, J. K. and Y-J. Surh. Molecular basis of chemoprevention by resveratrol: NF-κB and AP-1 as potential targets. Mutat. Res 555:65–80.(2004). PubMed | | Pozo-Guisado, E., A. Alvarez-Barrientos, S. Mulero-Navarro, B. Santiago-Josefat, and P. M. Fernandez-Salguero. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem. Pharmacol 64:1375–1386.(2002). CrossRef, PubMed, CSA | | Kuwajerwala, N., E. Cifuentes, S. Gautam, M. Menon, E. R. Barrack, and G. P V. Reddy. Resveratrol induces prostate cancer cell entry into S phase and inhibits DNA synthesis. Cancer Res 62:2488–2492.(2002). PubMed, CSA | | Baatout, S., H. Derradji, P. Jacquet, D. Ooms, A. Michaux, and M. Mergeay. Enhanced radiation-induced apoptosis of cancer cell lines after treatment with resveratrol. Int. J. Mol. Med 13:895–902.(2004). PubMed | | Zoberi, I., C. M. Bradbury, H. A. Curry, K. S. Bisht, P. C. Goswami, J. L. Roti Roti, and D. Gius. Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett 175:165–173.(2002). CrossRef, PubMed, CSA | | Scarlatti, F., G. Sala, C. Ricci, C. Maioli, F. Milani, M. Minella, M. Botturi, and R. Ghidoni. Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated with ceramide increase. Cancer Lett 253:124–130.(2007). CrossRef, PubMed | | Fiore, M., F. Festa, T. Cornetta, R. Ricordy, and R. Cozzi. Resveratrol affects X-ray induced apoptosis and cell cycle delay in human cells in-vitro. Int. J. Mol. Med 15:1005–1012.(2005). PubMed | | Duraj, J., J. BoDo, M. Sulikova, P. Rauko, and J. Sedlak. Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells. Neoplasma 53:384–392.2006. PubMed | | Ferry-Dumazet, H., O. Garnier, M. Mamani-Matsuda, J. Vercauteren, F. Belloc, C. Billiard, M. Dupouy, D. Thiolat, J. P. Kolb, and M. D. Mossalayi. Resveratrol inhibits the growth and induces apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 23:1327–1333.(2002). CrossRef, PubMed, CSA | | Vitrac, X., A. Desmouliere, B. Brouillaud, S. Krisa, G. Deffieux, N. Barthe, J. Rosenbaum, and J-M. Merillon. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 72:2219–2233.(2003). CrossRef, PubMed, CSA | | Horn, T. L., M. J. Cwik, R. L. Morrissey, I. Kapetanovic, J. A. Crowell, T. D. Booth, and D. L. McCormick. Oncogenicity evaluation of resveratrol in p53+ (p53 knockout) mice. Food Chem. Toxicol 45:55–63.(2007). CrossRef, PubMed | | Crowell, J. A., P. J. Korytko, R. L. Morrissey, T. D. Booth, and B. S. Levine. Resveratrol-associated renal toxicity. Toxicol. Sci 82:614–619.(2004). CrossRef, PubMed | | Juan, M. E., M. P. Vinardell, and J. M. Planas. The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J. Nutr 132:257–260.(2002). PubMed, CSA | | Dai, J. M., D. C. Sun, R. X. Lin, J. Yang, S. Lou, and S. Q. Wang. Microarray analysis of differentially expressed genes in mouse bone marrow tissues after ionizing radiation. Int. J. Radiat. Biol 82:511–521.(2006). CrossRef, PubMed | Gridley, D. A. and M. J. Pecaut. Whole-body irradiation and long-term modification of bone marrow-derived cell populations by low- and high-LET radiation. In Vivo20, 781–790 (2006). | | Greenberger, J. S., M. W. Epperly, N. Jahroudi, K. L. Pogue-Geile, L. A. Berry, J. Bray, and K. L. Goltry. Role of bone marrow stromal cells in irradiation leukomogenesis. Acta Haematol 96:1–15.(1996). CrossRef, PubMed | | Greenberger, J. S., J. Anderson, L. A. Berry, M. Epperly, E. P. Cronkite, and S. S. Boggs. Effects of irradiation of CBA/CA mice on hematopoietic stem cells and stromal cells in long-term bone marrow cultures. Leukemia 10:514–527.(1996). PubMed, CSA |